Plate VI · The catechism
GHK-Cu FAQ: Copper Peptide Questions, Answered From the Record
Twenty-three questions about GHK-Cu and copper peptides, each answered in a sentence or two from the cited literature — the hair, skin, mechanism, safety and pharmacokinetic record, weighed honestly.
Do copper peptides stimulate hair growth?
In a 6-month trial of 45 men with androgenetic alopecia, a topical 5-aminolevulinic-acid + glycyl-histidyl-lysine complex increased hair count by 52.6 (100 mg/mL) and 71.5 (50 mg/mL) versus 9.6 for placebo (p<0.05) [4]; preclinical mouse and follicle models report extended anagen and dermal-papilla proliferation [7]. The human evidence is one small combination-formulation trial, so this is research-stage, not a treatment claim.
Does copper peptide regrow hair?
A 2% GHK-Cu ionic-liquid microemulsion drove mouse follicles into anagen within 6 days (versus 9 for minoxidil) with higher hair density at 28 days and no change in testosterone or estradiol [14]; the strongest human signal is the 45-patient combination-formulation trial [4]. 'Regrow' is supported in the animal model and suggested in the small human trial.
Does copper peptide work for hair growth?
Research models report VEGF-driven follicular angiogenesis, collagen and glycosaminoglycan synthesis and anagen induction [6][14]; controlled human data are limited to one 45-patient combination-formulation RCT [4], so results are research-stage, not a treatment claim.
How long does GHK-Cu take to regrow hair?
Timelines come from study endpoints, not dosing guidance: a mouse microemulsion study saw anagen entry by day 6 and greater density by day 28 [14], and the human ALAVAX-type trial measured hair-count gains over 6 months [4].
Is copper a DHT blocker?
No. The studied copper-peptide hair mechanism is non-androgenic: a mouse study reported follicle anagen via Wnt/beta-catenin, VEGF and HGF with no change in testosterone or estradiol [14], distinct from DHT-pathway inhibitors.
How long do copper peptides take to work on hair?
In the cited preclinical model, follicles re-entered the active growth (anagen) phase within about 6 days and density increased by 28 days [14]; the controlled human trial measured outcomes at 6 months [4].
What does a GHK-Cu peptide do?
GHK-Cu is a copper-binding tripeptide that, at picomolar-to-nanomolar concentrations, stimulates fibroblast synthesis of collagen, elastin, glycosaminoglycans and decorin and rebalances matrix metalloproteinases against their TIMP inhibitors in research models [1][6].
What is GHK-Cu and how does it work?
GHK-Cu is the copper(II) chelate of the tripeptide glycyl-L-histidyl-L-lysine. It acts as both a copper chaperone and a signaling molecule, with copper coordination required for most documented matrix-remodeling activity — free GHK does not reproduce MMP-2 stimulation in fibroblast cultures [6].
Is GHK-Cu peptide really anti-aging?
Plasma GHK declines from about 200 ng/mL at age 20 to about 80 ng/mL by 60, and topical GHK-Cu increased collagen production in 70% of treated women versus 50% for vitamin C and 40% for retinoic acid in reviewed trials [3]; evidence is largely in vitro and topical, not systemic.
What is the difference between GHK and GHK-Cu?
GHK is the free tripeptide (MW 340.38); GHK-Cu is its copper(II) chelate (MW 402.92) [6]. Copper coordination is required for most tissue-repair activity, so studies on the free peptide and the copper complex are not interchangeable.
What does a copper peptide do for your skin?
In dermal research models GHK-Cu stimulates collagen, dermatan/chondroitin sulfate and decorin synthesis [3]; combined with low-molecular-weight hyaluronic acid it has raised collagen markers in fibroblasts, and small placebo-controlled trials report firmer skin and reduced wrinkle depth [10].
Does GHK-Cu actually increase collagen production?
In human fibroblast cultures GHK-Cu raised collagen synthesis dose-dependently (onset 10^-12 to 10^-11 M, peak near 10^-9 M) without changing cell number [1], and a review reported increased procollagen in 70% of treated subjects versus 50% for vitamin C and 40% for retinoic acid [3].
What are the downsides of copper peptides?
Reported concerns include low native topical bioavailability (free GHK clogP -2.24) [13], incompatibility with vitamin C and low-pH acids [11], a localized hyperpigmentation signal in some applications, and a theoretical copper-accumulation risk with prolonged systemic use; no human copper-toxicity cases attributed to GHK-Cu appear in the peer-reviewed record [3].
How long does it take GHK-Cu to tighten skin?
Topical study endpoints are typically measured over weeks to a few months; small placebo-controlled facial trials reported improved density, firmness and wrinkle depth over their study windows [3]. These are research timelines, not a usage recommendation.
Is GHK-Cu better than retinol?
A review reported topical GHK-Cu increased collagen production in 70% of treated women versus 40% for retinoic acid and 50% for vitamin C [3]; the two work by different mechanisms and are sometimes studied as complementary rather than as a direct substitution.
What shouldn't be mixed with GHK-Cu?
Formulation literature flags strong reducing agents and low-pH actives: ascorbic acid below about pH 3.5 reduces Cu(II) and breaks the complex, and AHAs/BHAs and other low-pH actives can destabilize it or compete for copper [11].
Does GHK-Cu affect inflammation?
Tissue-remodeling reviews report GHK-Cu suppresses free radicals, TGF-beta-1, TNF-alpha and protein glycation while chemoattracting repair cells [6]; the mechanism summary attributes anti-inflammatory action partly to NF-kB suppression. These are model-level findings, not a clinical anti-inflammatory claim.
Is GHK-Cu safe for long-term use?
Topical Copper Tripeptide-1 has a long cosmetic safety record, but no validated long-term human safety or pharmacokinetic data exist for injectable or systemic GHK-Cu, and a theoretical copper-accumulation risk is flagged for prolonged systemic use [3]. Site content describes research only, not a usage protocol.
Can GHK-Cu help with wound healing?
Across rodent and biomaterial models GHK-Cu accelerates wound closure by upregulating VEGF, FGF-2 and collagen and suppressing free radicals and TGF-beta-1; the foundational tissue-remodeling review documents this across multiple species [6], though robust human wound trials are still limited.
What genes does GHK-Cu affect?
A Connectivity Map analysis reports GHK modulates about 31.2% of human genes at a 50%-or-greater change threshold (59% up, 41% down), strongly stimulating the ubiquitin-proteasome system (41 genes up, 1 down) plus DNA-repair and antioxidant gene sets [2]; the often-quoted '~4,000 genes' figure is an extrapolation.
What is the neuroprotective research on GHK-Cu?
In vitro, GHK prevented copper- and zinc-induced protein aggregation and CNS-cell death by sequestering extracellular copper, and a biotinylated GHK-copper complex showed antioxidant and antiglycation activity against amyloid-beta/acrolein adducts [9]; rodent behavioral studies report anxiolytic effects [12]. This evidence is preclinical.
Can GHK-Cu cross the blood-brain barrier?
No validated human blood-brain-barrier permeability data exist. Neuroprotective rodent studies in the broader literature use intranasal delivery to reach the CNS, and the cited neuro work is in-vitro cell-culture [9] or rodent behavioral [12], not human pharmacokinetics.
Is copper peptide safe?
Topical Copper Tripeptide-1 has a long cosmetic safety record, but no validated long-term human safety or pharmacokinetic data exist for injectable or systemic GHK-Cu, and a theoretical copper-accumulation risk is flagged for prolonged systemic use [3]. This site describes the research record, not a usage protocol.